Matthew Robert Smith

10.6k citations
67 papers · 8.5k · 9 hit papers · h-index 30

Impact in

Papers in

Matthew Robert Smith

63 papers receiving 8.2k citations

Matthew Robert Smith's Hit Papers

Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial 2023 · 144 citations
1440+9+18Years since publication50010001.5k

Peers

Matthew Robert Smith
Comparison fields: 5 of 118
  • Pulmonary and Respiratory Medicine 4.5k
  • Oncology 3.4k
  • Cancer Research 1.0k
  • Orthopedics and Sports Medicine 536
  • Radiology, Nuclear Medicine and Imaging 1.4k
Replace Carsten Dietrich Goessl with:
Carsten Dietrich Goessl United States
Ingo Diel Germany
Catherine H. Van Poznak United States
Ronaldo Damião Brazil
Roger von Moos Switzerland
Juan Morote Robles Spain
S. Ashley United Kingdom
Umberto BASSO Italy
Justus Apffelstaedt South Africa
Matthew D. Guo United States
Matthew Robert Smith relative to Carsten Dietrich Goessl United States Carsten Dietrich Goessl's profile →
Citations per field
00.5×1.5×
Carsten Dietrich Goessl · 1×
Citations per year

Countries citing papers authored by Matthew Robert Smith

Since Specialization
Citations

This map shows the geographic impact of Matthew Robert Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Robert Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Robert Smith more than expected).

Fields of papers citing papers by Matthew Robert Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Robert Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Robert Smith. The network helps show where Matthew Robert Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Robert Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Robert Smith Line = papers co-authored together Matthew Robert Smith links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Hit paper breakdown →
20111545
2
Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
Hit paper breakdown →
1999880
3
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
Hit paper breakdown →
2019697
4
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Hit paper breakdown →
2011651
5
Changes in Body Composition during Androgen Deprivation Therapy for Prostate Cancer
Hit paper breakdown →
2002581
6
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Hit paper breakdown →
2017554
7
Pathologic fractures correlate with reduced survival in patients with malignant bone disease
Hit paper breakdown →
2007531
8
Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
Hit paper breakdown →
2012378
9 2003283
10 2012246
11 2008210
12 2013194
13 2011191
14
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
Hit paper breakdown →
2023144
15 2013133
16 2001120
17 2005119
18 200999
19 200282
20 201562

About Matthew Robert Smith

Matthew Robert Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 67 papers that have together received 8.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (35 papers), Bone health and treatments (25 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Hormonal and reproductive studies (5 papers), Cancer, Lipids, and Metabolism (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.5k citations), Oncology (3.4k citations), Cancer Research (1.0k citations), Orthopedics and Sports Medicine (536 citations) and Radiology, Nuclear Medicine and Imaging (1.4k citations). Matthew Robert Smith has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Karim S. Fizazi, Neal D. Shore, Carsten Dietrich Goessl, Ronaldo Damião, Roger Dansey, Michael Anthony Carducci, Janet Elizabeth Brown, Fred Saad, Huei Wang and Qi Jiang. Their work appears in journals such as The Journal of Urology, Journal of Clinical Oncology, European Urology, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact